radiation oncology clinics. The enrollment criteria were as follows: histologically confirmed diagnosis of high risk or intermediate risk PCa, 22 ADT (LH analogue, 10.8 mg every 3 months) scheduled for a total period of 36 months (3 to 5 months prior to RT, during and after completion), patients be fore RT (a total dose of 76 Gy in 38 fractions), 2, 3 good general condition (in Eastern Cooperative Oncology Group, performance status 0-1), and minimum 18 years of age. We excluded patients with distant metastases and/or disease progres sion resulting in RT or the introduction of chemo therapy; with insufficiently controlled arterial hy pertension or cardiac diseases resulting in circu lation failure (heart failure above class II accord ing to the New York Heart Association classifica tion) or uncontrolled asthma; with insufficiently controlled metabolic diseases or endocrine, rheu matic, and absorption disorders, as well as other tumors; with preexisting bone metastases at high risk for fracture; or with a psychiatric illness or dementia or organic brain disease.
Design and procedures
This was a 2 arm paral lel randomized controlled trial. The study ob tained ethics approval from the Poznan Univer sity of Medical Sciences (UMP No10/2012) and was registered at the ISRCTN Registry (Identifi er ISRCTN80 765 858). After obtaining primary oncologist's approval, potential patients were ap proached by a research physiotherapist or nurse and provided written informed consent to par ticipate in the study.
Randomization and blinding For allocating the par ticipants, a computer generated list of random numbers was used. Patients were randomly as signed to one of the study groups (exercise group vs usualcare [control] group) following simple randomization procedures. Concealed randomiza tion was conducted using sequentially numbered opaque envelopes containing group assignments provided to participants following the baseline assessment.
All patients underwent a series of base line assessments over 2 days, including com pletion of an on study form and a clinical re cord form, and were subsequently randomized to the intervention condition consisting of RT and ADT plus an individually tailored exercise program. The analysis excluded data of patients who withdrew from the study before completing the 12 month period of the study or patients in the control group who performed regular phys ical activity.
This study was not fully blinded; however, group allocation was concealed from the patients and the physiatrist until after the completion of the baseline assessments. A clinical research coordinator obtained patient consent, collected all the self reported assessments, and explained the exercise program to participants. Laboratory assistants, study statistician, and data managers remained blinded at all times. recurrence. 10, 11 It has been well documented that the incidence of cardiovascular events is signif icantly higher for individuals who smoke, have diabetes, hypertension, chronic pulmonary ob struction, high body mass index (BMI), high lev els of triglycerides (TGs) and creatinine, and low levels of high density lipoprotein (HDL) choles terol. However, even among study participants without these traditional risk factors, elevated lev els of inflammatory markers (interleukin [IL] 1β, IL 6, tumor necrosis factor α [TNF α]) prove to be the best predictors for coronary heart disease and congestive heart failure. [12] [13] [14] Physical exercise has been shown to be an ef fective, safe, and quite inexpensive method to re duce cardiovascular and metabolic risk factors, and it is currently being assessed with regard to its relevance for cancer specific morbidity and mortality. 9, 15 For example, exercise training has been shown to improve cardiorespiratory fitness, muscle strength, and some aspects of QoL in can cer patients. [16] [17] [18] Improving the QoL and psycho logical well being of men with PCa through sup portive care interventions such as exercise pro grams is a priority. [17] [18] [19] However, the long term effect of exercise during ADT with RT in patients with high grade PCa has been less extensively studied so far. 19, 20 Given the lack of research into the implications of long term regular physical ex ercise interventions for men with PCa during on cologic treatment, we adopted an exploratory ap proach to physical exercise as a potential predictor of changes in a range of cardiovascular risk factors and inflammatory marker levels as well as fatigue and QoL. Our hypothesis was that compared with physical activity recommendations (eg, perform 30 minutes of moderate/vigorous physical activity 5 d/wk), 21 a supervised exercise intervention would improve inflammatory and lipid status as well as cardiorespiratory capacity, reduce abdominal fat mass, and improve the levels of self reported QoL and fatigue during 1 year of ADT with and after RT. Thus, we aimed to compare short and long term effects of a supervised exercise program in patients with PCa on inflammatory marker levels, cardiovascular risk factors, and functional status.
Outcome measure The primary outcomes were changes in inflammatory factors, abdominal obe sity with lipid profiles, and aerobic capacity during 12 months. Secondary outcomes were changes in fatigue and QoL scores, caused by regular physi cal activity during oncologic treatment.
PATIENTS AND METHODS Setting and participants
This was an outpatient, regional clinical study conducted in the Greater Poland Cancer Centre, Poznań, Poland. Patients treated in the center came from the western region of Poland. Potential eligible participants were identified through a cen tral screening of PCa patients for RT in this hospi tal. Patients were recruited from December 2012 to December 2014, according to the study crite ria. Recruitment was conducted at urology and Our participants (in both groups) followed a normal, balanced diet (not restricted), which we monitored using the Mini Nutritional Assess ment (MNA). 25 Assessment scheme Participants underwent 3 outcome measure assessments: assessment I, at baseline (1 week before the onset of RT); as sessment II, 1 week after the end of RT (after 8 weeks of the program in the exercise group); as sessment III, final assessment after 10 months (12 months of the study time).
Measurements Demographic characteristics were age, education, and marital status. Clinical charac teristics were cancer stage and comorbidities (eg, high blood pressure, heart disease, arthritis, dia betes, asthma/emphysema, pain). This informa tion was collected through self report.
Laboratory assays The levels of inflammatory markers were measured in the Immunology De partment. Sera were stored at -80°C until the as say was performed. Serum levels of IL 1β, IL 6, and TNF α were measured using the BD™ Cy tometric Bead Array Enhanced Sensitivity Set system (BD Biosciences, San Diego, California, United States), according to the manufacturer's protocols. A standard curve was generated using known concentrations of the recombinant form of the human cytokine of interest. Samples were analyzed using a BD FACSCanto flow cytometer (BD Biosciences), and the results were calculat ed using FCAP Array TM Software Version 3 (BD Biosciences). The results were expressed in fg/ ml. The detection limit of the assay for IL 1β was 48.4 fg/ml; for IL 6, 68.4 fg/ml; and for TNF α, 67.3 fg/ml.
Venous Aerobic capacity Functional capacity was es timated using the 6 minute walk test (6MWT) protocol, which is used in clinical exercise tri als to estimate aerobic capacity in cancer pa tients. 26 The 6MWT was performed according to the American Thoracic Society guidelines. 27 It was followed by a short cool down period con ducted in a hospital corridor (30 meters). Sec ondary measures included dyspnea after the test using a modified Borg scale (0-10) and metabol ic equivalents (METs). This test can be used as Exercise intervention All exercise training ses sions in the exercise group consisted of 5 exercise sessions/wk for 8 weeks (during RT-between as sessments I and II), and 3 d/wk for the next 10 months. The physical activities were performed either individually (strength training performed with the assistance of a physiotherapist) or in groups (exercises on treadmills or cycle ergom eters, supervised by a therapist) and took place at a rehabilitation department.
During RT, optional progressive exercise train ing included brisk walking, running indoors or on a treadmill, various cycling activities (30 min), and 25minute resistance exercises (2 sets of 8 repetitions of 5 different exercises: bicep curl, triceps extension, leg extension, leg curl, and ab dominal crunch) at 70% to 75% of their estimat ed one repetition maximum. 23 All activities last ed approximately 65 to 70 minutes. The workout consisted of a 5 minute warm up and 55 minutes of physical activity, followed by a 5 minute re laxation period. The physical activity was mod erate, with a maximal heart rate of 65% to 70% (220 age).
After RT, the exercise group performed a very similar exercise program 3 times/wk (ie, 1 day of exercise and 1 day of rest), but 1.5 h/d in our de partment. Exercise sessions consisted of 5 min utes of light warm up and stretching, 40 minutes of middle impact aerobics, 35 minutes of resis tance training, and a 10 minute cool down includ ing relaxation. The prescribed aerobic intensity was 70% to 80% of heart rate reserve.
Usual care
Patients randomized to the control group received usual care and physical activity according to recommendations. 21 Clinicians pro vided medical clearance prior to the patients' in volvement in the study. Patients in this group were given standard physical activity recommen dations and were instructed via printed materi als to perform 30 minutes of moderate physical activity 5 d/wk (150 min/wk). Patients random ized to this group were instructed not to begin any formal physical activities and perform usual daily activity at home.
We measured the intensity of physical activi ty at baseline in both groups, and during assess ment II and at the end of the study in the con trol group, using the Godin Leisure Time Exer cise Questionnaire (GLTE). 24 Participants were asked to report their average weekly duration of light, moderate, and vigorous intensity activity in a typical week in the past month. 24 They were asked if they regularly engaged in any physical activity during their leisure time. If the answer was positive, they were also asked to choose ac tivities from a list of 20 activities and describe the frequency (times/wk) and the duration (min utes) for each of the activities chosen. 24 If the pa tient performed 3 of the 20 regular exercise or sports activities more than 3 times/wk and lon ger than 15 minutes, the data were not used for further analysis. the last observation carriedforward method was used. This analysis imputes the last value observed before dropout, regardless of when it occurred. The quantitative data was described us ing the mean and standard deviation. Homogene ity between samples was examined using the Ko mologorov-Smirnov 2 sample test. The analy sis showed that most parameters measured had normal distribution compatibility. Baseline char acteristics of the 2 groups were compared using 2 sample t tests for continuous variables and χ 2 tests for categorical variables. The analysis of vari ance (ANOVA) was used to examine the differ ence in means between the groups with regards to blood count levels, fatigue, and QoL. A corre lation analysis using the Pearson's r correlation coefficient was performed to establish the rela tionship between blood parameters and function al capacity, as well as blood parameters and Qol or fatigue. The weighted κ statistic was used as a measure of intraexaminer reliability, and intra class correlation coefficients were used as a mea sure of interexaminer reliability for each method. A method comparison analysis was performed to determine the 95% limits of agreement for all ex aminers. To avoid intertester variation, the same tester carried out all tests in the same individual.
RESULTS Study patients From a total of 826 patients with PCa screened for the study, 100 men enrolled in this trial were invited to partic ipate by their oncologist (according to the study criteria). Seventy four patients completed base line testing, but 2 men resigned from the study because of psychological contraindications (dis tress and depression) after general medical as sessment. As shown in the CONSORT diagram (FIGURE 1), 72 participants were randomly assigned to the exercise group (n = 36) or the control group (n = 36). During 1 year of the study, there were 5 dropouts (14%) in the control group and 1 (3%) in the exercise group; 66 men completed the inter vention and their data were included in the sta tistical analysis.
Patients who were excluded from the study due to cancer progression (in most cases, metastases to the bone tissue, internal organs) were first of all provided with oncologic treatment and had the possibility of individual rehabilitation un der separate conditions; one patient was exclud ed because of a stroke and was treated in a neu rology ward and referred to a neurorehabilitation ward; one patient from the control group with drew from the study.
Baseline characteristics of the participants are presented in TABLE 1.
Adherence and safety No significant differenc es were observed in daily physical activity lev els (according to the GLTE) at baseline, and in daily meals (according to the MNA) at baseline and during the 12 months of the study between the groups. Generally, the average adherence to the weekly supervised sessions was 86% in a predictor of functional (distance) and objective (VO 2max ) fitness. 28 Different studies have indepen dently shown that both the 6MWT and aerobic fitness are predictive of morbidity and mortali ty, and equations relating the 6MWT to peak ox ygen consumption (peak VO 2 ) have been recent ly developed for patients with cardiopulmonary disorders. 28, 29 The MET was calculated as a result of evidence suggesting that 3.5 ml/kg/min does not accurately represent the resting metabolic rate of a general population, standardized METs = (VO 2 /3.5 ml/kg/min) and measured METs = VO 2 /pretest metabolic rate. The pretest metabolic rate was deduced as the mean VO 2 in the minute prior to commencing the test. Gas analysis (Oxy con Mobile, CareFusion, Germany) was then used.
Questionnaires The Functional Assessment of Cancer Therapy-Fatigue (FACT F) scale was em ployed for a subjective assessment of fatigue in daily life of the patients. The FACT F question naire (version 4) is used to assess 5 domains of life in chronically ill patients. 30 Cella et al 31 also developed a 13 item subscale for the FACT F spe cifically to measure cancer related fatigue. Af ter accounting for reverse scored items, the an swers are summed across the subscales and add ed to provide a total score, with higher scores in dicative of less fatigue. All responses are scaled with a 5 point Likert type scale. The total score varies from 0 (worst condition) to 4 (best con dition). In the present study, the Polish version of FACT F (version 4), obtained from the suppli er's website (www.facit.org/FACITOrg/Question naires) was used.
The QoL was evaluated using the European Organization for Research and Treatment of Cancer (EORTC) questionnaires: QLQ C30 ver sion 3.0 and a specific module for prostate can cer-QLQ PR25. QLQ C30 is a self administered questionnaire specifically designed for the evalu ation of QoL in cancer patients during clinical tri als, and QLQ PR25 is a supplementary measure for PCa patients. 32, 33 The EORTC approved the use of these questionnaires in this study.
Data analysis A priori, we calculated the sam ple size necessary to detect a significant, clini cally important difference in outcome measures over time (group × time interaction effect, F sta tistic) between the exercise and control groups. The parameters of this calculation were as follows: α level of 0.05, power = 0.80, minimum 60 par ticipants required because the sample size ran domized to the exercise and control groups was 30 per each group.
Data analyses were conducted using the SPSS software (for Windows). Unless otherwise stated, all statistical tests were performed at the 2 tailed 5% level of significance. Exercise was the inter subject factor, while the intraobject factor com prised individual variables reflecting blood pa rameters, anthropometric measures, function al capacity, fatigue, and QoL. For missing data, paracetamol (0.5 g) or ibuprofen (0.25 g), which could not have affected the results because the dose was clinically insignificant.
Anthropometric parameters As regards body weight, violation of sphericity occurred and so the Greenhouse-Geisser correction was applied. Tests demonstrated significant differences be tween the exercise and control groups. After 12 months, body weight differed significantly from the measurements in assessments I and II. There were important differences between the groups: body weight was significantly higher in controls. Similar differences were observed for BMI and WHR. the exercise group. As regards the intervention based on exercises at home in the control group, trainees returned their training diaries report ing that they had accomplished vigorous home training 0.8 times/wk and endurance training 1.1 times/wk. The average time of an endurance training session was 48 minutes.
Participants did not take any anelgesics before exercise sessions. No severe side effects were re ported in any of the groups. However, 3 overuse injuries to the lower extremities were reported in the exercise group (ie, muscle pain and stiff ness). However, all these symptoms occurred af ter the first weekend break from exercise train ing, after which all these participants returned to their training. Those patients took no more than 2 tablets (only on the first day of the break): Quality of life The analysis of the QLQ C30 ques tionnaire scales revealed that there were no dif ferences in general health status. As for physical functioning, we observed significant differences between assessments I and II, as well as I and III.
The differences between the groups were not sig nificant. With regard to role functioning, there were no significant differences between the mea surements or the groups studied. As for cognitive functioning, we observed significant differences between assessments I and II. Men in the exercise group obtained significantly higher results com pared to those in the control group. There were significant differences in emotional functioning between assessments I and II, and the differenc es between the groups were significant in assess ment III. With regard to social functioning, there were nonsignificant differences between the mea surements or the groups, and other parameters analyzed. The result of the QLQ PR25 subscale analysis for sexual activity was P = 0.85. How ever, there were significant differences in sexual functioning between assessments I and II, and in the case of assessment III, a significant difference between the groups was observed. There were no significant differences in urinary problems be tween the measurements (P = 0.28). However, we noted a significant difference between the groups after RT: significantly higher result in the control group. As for bowel disorders, the exercise group showed a significant alleviation of symptoms. There were nonsignificant differences in side ef fects of hormonal therapy between the measure ments: P = 0.12, and there was a difference be tween the groups at 12 months (P <0.05). QoL changes are presented in TABLE 4 . DISCUSSION The role of physical exercise in pre venting diseases such as cardiovascular disease, type 2 diabetes, and cancer has been extensively studied. [15] [16] [17] To our knowledge, our study was one of the first to assess the physiological and psycho logical effects of a long term supervised exercise program in men with high grade PCa during on cologic therapy. This trial was an extension of our previous study, 34 which focused on the impact of exercise training during RT on radiation toxicity in these patient group. The idea to conduct our study stemmed from the research on the role of regular exercise in preventing diseases associat ed with chronic low grade systemic inflamma tion (eg, metabolic syndrome, cardiovascular dis ease), 35, 36 especially in PCa patients.
Blood parameters There were no significant dif ferences in the lipid parameters between the mea surements. However, the analysis showed sig nificant differences in the levels of AST and ALT between the measurements, but not between the groups.
Inflammatory markers As for cytokines, there was no significant difference in IL 1β levels between the groups (P = 0.18). In the case of IL 6 levels, there were significant differences between indi vidual measurements. The highest IL 6 level was observed after RT, and this result was significantly higher in both groups compared to the other mea surements. There were also differences (at the lev el of statistical significance, P <0.1) in TNF α lev els between individual measurements. The high est TNF α level was observed in assessment II, and it was significantly higher than in assess ments I and III. The results in the exercise group were lower than in the control group, but the dif ference between the groups was not significant.
Aerobic capacity The analysis of the 6MWT dis tance did not show any significant differences be tween measurements at baseline in both groups (P = 0.88). However, in subsequent assessments, the distance was significantly higher in the exer cise group. As for MET, the data tests did not re veal any significant differences between assess ments I and II (P = 0.89) but revealed significant differences between the groups in assessments II and III (MET was significantly higher in the ex ercise group). The results of anthropometric measures, labo ratory assays, and 6MWT are presented in metabolic syndrome, 6,7,9,11 especially when com bined with RT 10 in men with PCa. On the other hand, the cytokines measured are well known as clinically useful mediators of cardiovascular dis eases and risk factors. [12] [13] [14] 37 In our study, we mea sured weight (BMI) and central obesity (WHR) and lipid profile as important predictors of car diovascular diseases.
38
Cross sectional studies demonstrated an asso ciation between physical inactivity and low grade systemic inflammation and cardiovascular risk in healthy subjects or in elderly people. 15, 36, 39 The re sults of the study by Leisegang et al 40 suggested
Recent papers have underlined the problem of the effect of oncologic treatment on cardiovascu lar risk in this group of patients. [9] [10] [11] In our study, we observed that supervised regular exercise training decreased inflammation, reduced car diovascular risk, and improved functional status in men with high grade PCa during ADT with RT. The exercise program prescribed (duration, fre quency, and intensity) was designed in accordance with the American Cancer Society recommen dations for cancer patients. 21 It has been recog nized that ADT is conducive to obesity and thus can increase the risk of cardiovascular diseases or Data are presented as mean ± SD. a significant differences between assessments II and I of the parameter in the same group b the level of statistical change between assessments I, II, and III of the parameter Conversion factors to SI units are as follows: PSA, 1.0; TC, LDL-C, and HDL-C, 0.0259; TG, 0.0113; AST and ALT, 0.0167; IL-1β and IL-6, 0.131, and TNF-α, 0.318.
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; HDL, high -density lipoprotein; IL -1, interleukin 1; IL -6, interleukin 6; LDL, low-density lipoprotein; MET, metabolic equivalent; TG, triglyceride; TNF -α, tumor necrosis factor α; others, see TABLE 1 in the exercise group after RT and 1 year of study and deterioration of this parameters in the con trol group. Similar effects were observed by oth er researchers. 17, 19 The second outcome of our study was the sub jective assessment of the functional status of the patients, measured with the EORTC and FACT questionnaires as scores recommended for cancer patients. [30] [31] [32] Since the groups did not differ much at baseline, we assumed that improvements in a greater number of EORTC functions and symp toms after RT and 12 months in the exercise group might be due to a better use of the physical train ing program. Even though we did not observe sig nificant changes in the general health status in any of the study groups, physical or emotional functioning was better in the exercise group in contrast to controls. Fatigue levels were higher in the exercise group at baseline. This changed significantly in the measurement after RT and after 1 year of study-fatigue levels in the exer cise group were significantly lower compared with controls. A similar effect of the exercise program in the exercise group was observed with regard to side effects of ADT, which were considerably less pronounced and burdensome; thus physical activity considerably alleviated problems caused by ADT. Similar results were observed by numer ous authors.
16-19
The results of our study also indicated that physical activity is conducive to good sexual func tioning. Even though at baseline men in the con trol group assessed their sexual functioning more positively compared with the exercise group, phys ical activity undertaken during the treatment im proved the quality of sex life in the exercise group. These results are similar to those obtained by oth er authors (Cormie et al 39 and Dahn et al) 46 , sug gesting that exercise has a beneficial effect on that TNF α, IL 1β, and IL 6 play a direct role in metabolic syndrome. On the other hand, the same cytokines are clinically useful as radiation related biomarkers, and oncology studies have focused on their use in predicting tumor response. 41, 42 After the study, we observed a lower increase of those parameters in the exercise group compared with controls after RT and at the end of the study. This was possible due to anti inflammatory effect of the physical training performed by the exercise group. 43 Our patients demonstrated a significant increase of cytokine levels after RT (smaller in the exercise group), which was the result of ra diation toxicity.
34
Our results confirm the conclusions reached by other authors about the positive effect of ex ercise on anti inflammatory factors in patients with high risk of metabolic syndrome and cardio vascular diseases. 39, 44, 45 Following the statistical measurement of the relationship between cyto kine levels and lipid or anthropometric parame ters, we did not observe any significant correla tions in any of the groups during our study, de spite clinically positive observations in the ex ercise group. However, the lipid profile did not change significantly in any of the groups during the study, and the levels of lipid parameters were not clinically important (our patients had simi lar diet measured by the MNA). Cormie et al 39 did not observe important changes in the same lipid parameters after 3 months of exercise training in patients with PCa starting ADT.
Another aspect of cardiovascular risk monitor ing in our trial was the functional/aerobic capac ity, measured with the 6MWT according to rec ommendations for cancer patients. 26, 29 We ob served a signficant improvement of functional capacity (increase in the 6MWT distance and de crease in dyspnea measured with the Borg scale) Data are presented as mean ± SD. a significant differences between assessments II and I of the parameter in the same group b the level of statistical change between assessments I, II, and III of the parameter the proinflammatory effect of obesity, improv ing nonspecific cancer related symptoms, cardio vascular risk factors related to cancer treatment, and improving QoL in patients with PCa. 47 Phys ical activity positively correlates with improve ment in sexual functioning and mental health and decreases side effects of oncologic therapy, preserving sexual function in men who were sex ually active before initiating ADT.
The results of our study confirm scientific data indicating that regular physical activity re duces the levels of systemic inflammatory me diators, and thus exercise may constitute an ac cessible and cost effective means of reducing conception, critical revision for intellectual con tent, and final approval of the manuscript.
including fatigue, in those patients who under went RT and ADT during PCa treatment. We be lieve that the differences in our results between the control and exercise groups were caused by poorer ability of patients on usual care to follow the physical activity program, possibly because of a lower level of motivation due to emotional rea sons. This might have reduced the ability of these patients to participate in daily physical activity despite recommendations from the medical staff.
Strengths and limitations Our study has method ological strengths. First, it was a randomized con trolled trial adequately powered to detect chang es in the levels of inflammatory and metabolic pa rameters between the control and exercise groups. Second, our laboratory staff were blinded to group assignment. Third, we standardized exercise ac tivity using a training routine that had strict pa rameters for training volume (repetitions, sets, heart rate, etc.). Fourth, we utilized both objective and subjective validated measures of well being.
Another strength was the use of well established self rating instruments with good psychometric properties. A limitation of this study was the lack of a relevant comparison group and more data re garding medical scans (imaging) during our trial.
Conclusions To conclude, the long term super vised exercise training is more effective than edu cational materials on physical activity in decreas ing cardiovascular risk and improving functional and emotional status or fatigue in patients with high grade PCa during RT and ADT. Future large scale efficacy trials are needed to replicate our findings across a wider range of men with PCa, to examine more biomarker outcomes at longer follow up periods, and to help deter mine the mechanisms (ie, psychological and emo tional factors and/or improved physical fitness or bone strength) responsible for these outcomes. Our findings can help determine the effective ness of rehabilitation for the prevention and man agement of metabolic diseases in men with PCa.
Implications for clinical practice There is strong evidence for the use of exercise/physical rehabil itation in reducing cardiometbolic risk, fatigue, and improving functional status during oncologic therapy of PCa. There is preliminary evidence indi cating that a number of areas, such as sexual and emotional functioning, may be improved by exer cise interventions in men with PCa during ADT.
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